glp 1 agonist cardioprotective GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes Cardiovascular effects of Glucagon-like peptide

Learn about GLP-1 agonists, what they can help treat, and how they work to promote weight loss

Learn how GLP-1 drugs can help you lose weight, which ones are best, and where to get them.

By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy

THURSDAY, Dec

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

Discover how Retatrutide works through its triple-pathway mechanism (GLP-1, GIP, glucagon), how it affects metabolism, and when results may begin.